For their study, researchers assessed remission rates and complication rates for 41 patients who underwent EMR for BE removal from Jan. 2006-Dec. 2010. Remission of high-grade dysplasia and cancer; all dysplasia; and all BE was 94.6 percent, 85.4 percent and 78 percent, respectively. However, patients also experienced minor bleeding (31.7 percent), perforations (4.9 percent) and strictures (43.9 percent).
Related Articles on GI Studies:
Study: Double Balloon Endoscopy is Safe, Effective
Celiac Cases Rising, Cause Unknown
Fatalistic Attitude Toward Cancer Key Factor in Low Screening Rates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
